You are here:
The Oregon Health Authority, operating under
OAR 415.020, is in charge of helping and regulating addiction prevention and treatment services in Oregon. Opioid Treatment Programs dispense and administer medications for the treatment of opioid addiction. This includes delivery of counseling, supportive services and medical services to program participants.
Opioid addiction is one of Oregon’s most pressing public health issues.
Medication-Assisted Treatment (MAT), including the use of methadone, is a medically monitored therapeutic intervention designed to assist opiate dependent individuals improve their overall quality of life and begin the recovery process, that involves case management, counseling and medication management.
Currently, in the United States:
As with any medication-based intervention, engagement in treatment and a psychosocial support system can contribute greatly to the patient's success.
Methadone is a full antagonist (fully blocking the opioid receptors in the brain). Research shows several positive benefits to methadone reatment, including:
Buprenorphine and naltrexone are also available for medication-assisted treatment of opioid dependence.
Methadone, buprenorphine and naltrexone are all highly effective medications for the treatment of opioid dependence. They may or may not be appropriate for the patient based on several other factors.
Program and Policy Development SpecialistState Opioid Treatment Authority
Know your rights:
Medicare reimbursement for opioid use disorder treatment services:
Billing Oregon Medicaid for Medication-Assisted Treatment (MAT)
MAT program/provider certification, requirements and resources on the Substance Abuse and Mental Health Services Administration website
Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how